Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002249 · ClinicalTrials.gov registry record · Phase 1
A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
A Phase 1 study, sponsored by R W Johnson Pharmaceutical Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002249 is a Phase 1 study that has completed, run by R W Johnson Pharmaceutical Research Institute.
The verdict
NCT00002249, a Phase 1 study, has completed, sponsored by R W Johnson Pharmaceutical Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection.
Interventions
- DRUG Levofloxacin
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002249
The ClinicalTrials.gov registry entry for NCT00002249 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is R W Johnson Pharmaceutical Research Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levofloxacin is the first listed.
NCT00002249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002249 about?
NCT00002249 is a clinical study titled "A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection". To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection.
What is the current status of trial NCT00002249?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00002249?
The interventions under investigation include: Levofloxacin (DRUG).
Who is sponsoring clinical trial NCT00002249?
This trial is sponsored by R W Johnson Pharmaceutical Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.